Detection of T790M, the Acquired Resistance <i>EGFR</i> Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses
Tilak Sundaresan(Kaiser Permanente San Francisco Medical Center), Daniel A. Haber(Howard Hughes Medical Institute), Helena A. Yu(Memorial Sloan Kettering Cancer Center), Douglas B. Fox(Harvard University), James P. Sullivan(Australian National University), Ravi Kapur(Harvard University), Jeffrey A. Engelman(Cancer Research Center), John V. Heymach(The University of Texas MD Anderson Cancer Center), Pasi A. Jänne(Harvard University), Walter Koch(Materials Systems (United States)), Bruce E. Johnson(Harvard University), Hai T. Tran(The University of Texas MD Anderson Cancer Center), Uma Giri(The University of Texas MD Anderson Cancer Center), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), Andrew I. Webb(The University of Melbourne), Shyamala Maheswaran(Massachusetts General Hospital), Shannon L. Stott(Shriners Hospitals for Children - Erie), Lecia V. Sequist(Harvard University), Mehmet Toner(Center for Cancer Research), John R. Walsh(Massachusetts General Hospital), Wen Wei(Materials Systems (United States)), Robert Maher(Harvard University), Martin Fleisher(Lamont-Doherty Earth Observatory), Thomas A. Barber(Massachusetts General Hospital), Alona Muzikansky(Johns Hopkins University)
Cited by 345
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k